Atlas Trials

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

Clinical trial NCT00676520 · COMPLETED

Trial details

NCT number
NCT00676520
Sponsor
Abbott Medical Devices
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Artery Disease
Start date
2008-07-01
Primary completion
2011-03-01
Enrollment
8053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.